Hepatic venous outflow reconstruction in right live donor liver transplantation

Massimo Malago, Ernesto P. Molmenti, Andreas Paul, Silvio Nadalin, Hauke Lang, Arnold Radtke, Chao Liu, Andrea Frilling, Reza Biglarnia, Christoph E. Broelsch – 17 February 2005 – The increasing experience with live donor liver transplantation has allowed for the identification of potential morbidities associated with technical considerations. Technical graft failure can be associated with both inflow and outflow vascular compromise. Although the latter has not always been given the relevance of the former, evidence pointing to its pivotal role continues to mount.

New hepatic vein reconstruction in left liver graft

Nobuyuki Takemura, Yasuhiko Sugawara, Takuya Hashimoto, Nobuhisa Akamatsu, Yoji Kishi, Sumihito Tamura, Masatoshi Makuuchi – 17 February 2005 – The incidence of hepatic venous stenosis is higher in partial liver transplantation. New methods for hepatic venous reconstruction in left liver transplantation, which secure wide anastomosis, were devised and are reported here. In the graft, the right side of the middle hepatic vein or the left side of the left hepatic vein was cut longitudinally and a rectangular‐shaped vein patch was attached for venoplasty.

MARS treatment for a patient presenting with acquired hepatic glutamine synthetase deficiency after orthotopic liver transplantation

Alexander Chiu, Sidney Tam, Wing Yan Au, See Ching Chan, Chi Leung Liu, Sheung Tat Fan – 17 February 2005 – We report a 48‐year‐old man presenting with refractory hyperammonemia after orthotopic liver transplantation. On investigation he was found to have acquired hepatic glutamine synthetase deficiency, a rare condition that occurs after organ transplantations. The patient was started on continuous venovenous hemofiltration treatment, but the hyperammonemia did not respond.

Microchimerism after liver transplantation: Absence of rejection without abrogation of anti‐donor cytotoxic T‐lymphocyte–mediated alloreactivity

Florence Bettens, Jean‐Marie Tiercy, Nathalie Campanile, Emiliano Giostra, Pietro Majno, Laura Rubbia, Eddy Roosnek, Gilles Mentha, Jean Villard – 17 February 2005 – Microchimerism (MC) is defined by the persistence of <1% circulating donor cells resulting from cell migration from the graft; MC may play a role in the induction of unresponsiveness to allogeneic tissues, or may be merely the consequence of the graft's acceptance following immunosuppression.

Splitting of the middle hepatic vein in full‐right full‐left splitting of the liver

Dieter C. Broering, Pamela Bok, Lars Mueller, Christian Wilms, Xavier Rogiers – 17 February 2005 – Full‐right/full‐left splitting of the liver offers a chance to overcome the severe shortage of donor organs. During this procedure, the splitting surgeons are always faced with the question of how to share the middle hepatic vein (MHV), since this vein drains parts of both halves of the liver. Consequently, we developed a procedure that splits the MHV, thus creating an MHV on both grafts. In this short article, we report on this splitting technique and our first initial experience.

Long‐term outcome of pediatric liver transplantation for biliary atresia: A 10‐year follow‐up in a single center

Virginie Fouquet, Arnaud Alves, Sophie Branchereau, Sophie Grabar, Dominique Debray, Emmanuel Jacquemin, Denis Devictor, Philippe Durand, Catherine Baujard, Monique Fabre, Danielle Pariente, Christophe Chardot, Bertrand Dousset, Pierre‐Philippe Massault, Denis Bernard, Didier Houssin, Olivier Bernard, Frédéric Gauthier, Olivier Soubrane – 21 January 2005 – The aim of this study was to review our experience in orthotopic liver transplantation (OLT) for biliary atresia (BA) in children and analyze the survival and prognostic factors, and long‐term outcome.

How common is delayed cyclosporine absorption following liver transplantation?

Silvina E. Yantorno, Eva B. Varela, Sebastián R. Raffa, Valeria I. Descalzi, Maria L. Gomez Carretero, Daniel A. Pirola, Andres E. Ruf, Gretel I. Martinez Carabuz, Luis G. Podesta, Federico G. Villamil – 21 January 2005 – The mean time to peak absorption of cyclosporine (CsA) in liver transplant patients is approximately 2 hours, but in some patients the peak occurs later. The goal of this study was, therefore, to investigate the incidence of delayed absorption in 27 de novo liver transplant recipients receiving CsA ≥10 mg/kg/day (C2 monitoring) and in 15 maintenance patients.

Subscribe to